Fig. 3From: Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapyKaplan-Meier survival curves stratified by PLR in prostate cancer patients with non-metastasis (I) and metastasis (II). a Progression-free survival (PFS), b Cancer-specific survival (CSS) and c Overall survival (OS)Back to article page